Company intelligence / Profile preview

The Oncology Institute

Cerritos, California, United Statestheoncologyinstitute.com ↗

Ownership: Private
Employees: ~800
Development stage: Commercial

Overview

TOI delivers value-based oncology care to over 1.8 million patients with more than 100 clinicians across 70+ clinics. It offers access to clinical trials—including Phase 2/3 studies—transfusions, stem cell transplants, and advanced cancer therapies. It has served over a quarter million unique patients since its founding in 2007. Participates as a site for industry-sponsored clinical trials such as the Phase 2/3 BRUIN trial for CLL/small lymphocytic lymphoma using pirtobrutinib versus standard-of-care therapy.

Therapeutic areas: Oncology
Modalities: Clinical care (chemotherapy, immunotherapy)clinical trials (various investigational agents)transfusions
Industry: Non-Academic Healthcare

Partnerships

Collaborates with pharmaceutical sponsors on multi-center oncology clinical trials but no major exclusive partnerships disclosed.

Beyond the preview

Go deeper on The Oncology Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Oncology Institute.

Explore the full profile